• Welcome
  • About
  • Issues
  • Feedback

Q&A Marguerite White

The state of medicinal cannabis in Australia today

Stories from the Frontline: Jo Beckett, Youth Projects

NSP Workers Report Growing Trend of Problematic Steroid Use

Q&A Cheryl Delalande

New Drug Price Regime Raises Questions

Hope on the Horizon: Trials target pharmacotherapy for methamphetamine use

Drugs and the 2022 Federal Election

Q&A Donna Garcia

Budget benefit: harm reduction affirmed in federal funding plan

Back to Penington Institute

Penington Institute is a community-based, not-for-profit organisation that actively supports the adoption of approaches to drug use which promote safety and human dignity. Penington Institute connects substance use research to practical action and supports Needle and Syringe Programs (NSPs) and other evidence-based approaches to reduce drug-related harm.

DISCLAIMER:

The Bulletin is published by Penington Institute and funded by the Australian Government. The views expressed are not necessarily those of the Australian Government or Penington Institute. Penington Institute takes no responsibility for loss or damage that may result from any actions taken based on materials within The Bulletin and does not indemnify readers against any damage incurred. All written material in this publication may be reproduced with the following citation: “Reprinted from vol. [x], ed. [y] of The Bulletin, published by Penington Institute, with credit to the author(s).”

Copyright 2022 All rights reserved.

Penington Institute
95 Drummond Street
Carlton VIC 3053

D: +61 3 9650 0699
F: +61 3 9650 1600
E: info@penington.org.au
W: www.penington.org.au
T: @peningtonnews

Facebook
Twitter
LinkedIn